Arcutis Biotherapeutics, Inc. financial data

Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3027 Townsgate Road, Suite 300, Westlake Village, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Arcutis, Inc. (to 9/9/2019)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 809 % -25.4%
Quick Ratio 28.9 % +39.4%
Debt-to-equity 185 % +35.2%
Return On Equity -145 % +23%
Return On Assets -51 % +36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 117M shares +89.6%
Common Stock, Shares, Outstanding 116M shares +89%
Entity Public Float 487M USD -44.6%
Common Stock, Value, Issued 12K USD +100%
Weighted Average Number of Shares Outstanding, Basic 123M shares +101%
Weighted Average Number of Shares Outstanding, Diluted 123M shares +101%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 30.9M USD +495%
Research and Development Expense 92.5M USD -43.7%
General and Administrative Expense 84.8M USD +123%
Costs and Expenses 80.9M USD +12.5%
Operating Income (Loss) -180M USD +43.1%
Nonoperating Income (Expense) -14.6M USD -354%
Income Tax Expense (Benefit) 3.44M USD
Net Income (Loss) Attributable to Parent -199M USD +39.9%
Earnings Per Share, Basic -2.05 USD/shares +63.1%
Earnings Per Share, Diluted -2.05 USD/shares +63.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.3M USD -19.8%
Accounts Receivable, after Allowance for Credit Loss, Current 43.4M USD +152%
Inventory, Net 13.9M USD +32.5%
Assets, Current 435M USD +40.7%
Property, Plant and Equipment, Net 1.35M USD -27.9%
Operating Lease, Right-of-Use Asset 2.16M USD -15%
Intangible Assets, Net (Excluding Goodwill) 6.06M USD -11%
Other Assets, Noncurrent 595K USD -0.17%
Assets 445M USD +38.7%
Accounts Payable, Current 7.94M USD -53.7%
Employee-related Liabilities, Current 10M USD +11.8%
Accrued Liabilities, Current 42.6M USD +127%
Liabilities, Current 51.4M USD +40.1%
Operating Lease, Liability, Noncurrent 2.98M USD -20.7%
Other Liabilities, Noncurrent 194K USD
Liabilities 258M USD +7.56%
Accumulated Other Comprehensive Income (Loss), Net of Tax -294K USD -0.69%
Retained Earnings (Accumulated Deficit) -1.07B USD -22.8%
Stockholders' Equity Attributable to Parent 186M USD +132%
Liabilities and Equity 445M USD +38.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.6M USD +60.7%
Net Cash Provided by (Used in) Financing Activities 162M USD
Net Cash Provided by (Used in) Investing Activities -28.7M USD -127%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 116M shares +89%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 101M USD +269%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 84.9M USD -19.9%
Deferred Tax Assets, Valuation Allowance 216M USD +32.8%
Deferred Tax Assets, Gross 217M USD +32.5%
Operating Lease, Liability 4.12M USD -13.8%
Depreciation 766K USD +18.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -199M USD +39.7%
Lessee, Operating Lease, Liability, to be Paid 4.81M USD -16.7%
Property, Plant and Equipment, Gross 3.46M USD +14.1%
Operating Lease, Liability, Current 777K USD +11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD +3.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 994K USD +3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 695K USD -30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.05M USD +2.93%
Deferred Tax Assets, Operating Loss Carryforwards 152M USD +44.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 41.4M USD -2.62%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09M USD +3.13%
Operating Lease, Payments 241K USD +36.9%
Additional Paid in Capital 1.26B USD +32%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 750K USD 0%
Share-based Payment Arrangement, Expense 41.3M USD +8.39%
Interest Expense 30.2M USD +44.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%